Capricor Therapeutics Inc CAPR

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Wall Street Analysts Predict a 218.18% Upside in Capricor (CAPR): Here's What You Should Know

13d ago, source: Zacks.com on MSN

Shares of Capricor Therapeutics (CAPR) have gained 11.9% over the past four weeks to close the last trading session at $6.60, but there could still be a solid upside left in the stock if short-term ...

Capricor: Q4 Earnings Snapshot

1mon ago, source: Houston Chronicle

SAN DIEGO (AP) — SAN DIEGO (AP) — Capricor Therapeutics Inc. (CAPR) on Thursday reported a loss of $762,000 in its fourth quarter. The San Diego-based company said it had a loss of 2 cents per ...

CADL Candel Therapeutics, Inc.

19h ago, source: Seeking Alpha

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase II clinical ...

Capricor Therapeutics Inc CAPR

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Capricor Therapeutics Inc.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Capricor Therapeutics Inc (CAPR)

1mon ago, source: Investing

Capricor Therapeutics (NASDAQ:CAPR) has completed enrollment in their Phase III HOPE-3 pivotal trial for Duchenne muscular dystrophy (DMD) treatment with their lead program, ...

Capricor Therapeutics Inc (CAPR)

7d ago, source: Investing

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...